Veterinary Medicines

VANGUARD 7

Not authorised
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parainfluenza virus, strain NL-CPI-5, Live
  • Canine distemper virus, strain N-CDV, Live
  • Canine parvovirus, strain NL-35-D, Live
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
Download as PDF

Product identification

Medicine name:
VANGUARD 7
Active substance:
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parainfluenza virus, strain NL-CPI-5, Live
  • Canine distemper virus, strain N-CDV, Live
  • Canine parvovirus, strain NL-35-D, Live
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine adenovirus 2, strain Manhattan, Live
    1584.89
    50% tissue culture infectious dose
    /
    1.00
    unit(s)
  • Canine parainfluenza virus, strain NL-CPI-5, Live
    5011870.00
    50% tissue culture infectious dose
    /
    1.00
    unit(s)
  • Canine distemper virus, strain N-CDV, Live
    1000.00
    50% tissue culture infectious dose
    /
    1.00
    unit(s)
  • Canine parvovirus, strain NL-35-D, Live
    10000000.00
    50% tissue culture infectious dose
    /
    1.00
    unit(s)
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
    463.00
    relative unit(s)
    /
    1.00
    unit(s)
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
    420.00
    relative unit(s)
    /
    1.00
    unit(s)
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AI02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
  • Surrendered
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Zoetis France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/6862556 2/1995
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 5/12/2022
Download